Pluri Inc. (NASDAQ:PLUR) Short Interest Update

Pluri Inc. (NASDAQ:PLUR) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 10,100 shares, a growth of 18.8% from the November 30th total of 8,500 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average daily trading volume, of 25,800 shares, the short-interest ratio is currently 0.4 days.

Pluri Stock Down 0.7 %

PLUR traded down $0.03 during trading on Tuesday, reaching $4.28. The company had a trading volume of 8,906 shares, compared to its average volume of 18,271. The business’s fifty day moving average price is $4.89 and its 200 day moving average price is $5.23. The company has a debt-to-equity ratio of 4.44, a current ratio of 5.90 and a quick ratio of 5.90. Pluri has a 12 month low of $4.07 and a 12 month high of $8.48. The company has a market cap of $23.79 million, a P/E ratio of -0.71 and a beta of 1.64.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.